Literature DB >> 28471689

The effect of tonsillotomy on chronic recurrent tonsillitis in children.

Elisabeth Foki1, Rudolf Seemann2, Klaus Stelter3, Claudia Lill1.   

Abstract

OBJECTIVES: The objective of this study is to determine whether partial tonsillectomy (tonsillotomy) impacts the occurrence of acute or recurrent tonsillitis in children.
METHODS: One hundred and eighty patients (1-14 years) were retrospectively surveyed by a questionnaire or by data analysis of a regional database. Subjects who suffered from severe systemic diseases or immunodeficiency syndromes were excluded. Episodes of acute tonsillitis before and after surgery, rate of antibiotic treatment, postoperative hemorrhage, and re-operation were obtained.
RESULTS: Fifty-one patients suffered from preoperative tonsillitis. The rate of reinfection was 9.8%. The frequency of tonsillitis was significantly reduced in children after tonsillotomy (p < .001). Further, tonsillotomy led to a significant reduction of antibiotic treatment (p < .001). The rate of definitive tonsillectomy was 1.1% and thus effectiveness was very high. About 1.7% of all children suffered from postoperative bleeding, of which one (0.6%) required surgical revision. None of the bleedings was life threatening.
CONCLUSIONS: Tonsillotomy is beneficial for patients with recurrent tonsillitis and carries less risk of postoperative complications than tonsillectomy.

Entities:  

Keywords:  Tonsil surgery; inflammation; post-tonsillectomy complications; throat infections

Mesh:

Year:  2017        PMID: 28471689     DOI: 10.1080/00016489.2017.1322712

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Tonsillotomy versus Tonsillectomy for Chronic Recurrent Tonsillitis in Children.

Authors:  Yaser Said Çetin; Ufuk Düzenli
Journal:  Turk Arch Otorhinolaryngol       Date:  2019-10-05

2.  Subtotal intracapsular tonsillectomy may be the first choice for tonsillectomy in children.

Authors:  Jie Wang; Pan-Hong Dang; Huan-Huan Chang; Zi-Han Wang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.